{"nct_id":"NCT05964413","title":"Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum","status":"TERMINATED","status_verified_date":"2025-07","start_date":"2023-11-01","start_date_type":"ACTUAL","primary_completion_date":"2025-07-11","primary_completion_date_type":"ACTUAL","completion_date":"2025-07-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["IFRX"]}